MedPath

A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

Phase 2
Active, not recruiting
Conditions
Atopic Dermatitis
Interventions
Drug: Placebo
Registration Number
NCT05911841
Lead Sponsor
Eli Lilly and Company
Brief Summary

The main purpose of this study is to describe the efficacy and safety of LY3454738 in adult participants with moderate-to-severe atopic dermatitis (AD).

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
236
Inclusion Criteria
  • Are candidates for systemic therapy.

ISA specific:

  • Have moderate-to-severe AD, defined as meeting all of the following criteria, at the first dosing visit:

    • EASI score greater than or equal to (≥)16
    • vIGA-AD score ≥3, and
    • ≥10% of BSA involvement (per EASI BSA).
  • Have applied at least 1 emollient every day for at least 2 weeks before the day of the first dose of study intervention in this ISA and agree to daily use of at least 1 emollient continuously throughout the study.

Exclusion Criteria

ISA specific:

  • Have, in the screening period, any of the skin conditions, infections, or medical conditions listed under master IMMB.
  • Are currently being treated with topical or systemic therapy
  • Recent treatment with experimental (biologics and/or small molecules) - doesn't apply for subset of participants who must have been exposed to biologics and/or small molecules.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LY3454738 Dose 1LY3454738Participants will receive LY3454738 subcutaneously (SC).
PlaceboPlaceboParticipants will receive placebo.
LY3454738 Dose 3LY3454738Participants will receive LY3454738 SC.
LY3454738 Dose 2LY3454738Participants will receive LY3454738 SC.
Primary Outcome Measures
NameTimeMethod
Percentage of Participants Achieving Eczema Area and Severity Index (EASI) 75Week 16
Secondary Outcome Measures
NameTimeMethod
Percentage of Participants Achieving SCORing Atopic Dermatitis (SCORAD) 75Week 16
Percentage of Participants Achieving Validated Investigator's Global Assessment for AD (viGA-AD) of 0 or 1Week 16
Mean Percent Change from Baseline in EASIBaseline, Week 16
Percentage of Participants Achieving EASI-75Week 16
Percentage of Participants Achieving SCORAD-90Week 16
Pharmacokinetics (PK): Serum Trough Concentrations of LY3454738Baseline to Week 16
Percentage of Participants Achieving EASI-90Week 16
Mean Percent Change from Baseline in SCORADBaseline, Week 16
Percentage of Participants Achieving EASI-50Week 16
Percentage of Participants Achieving ≥4-point improvement from baseline in Itch Numeric Rating Scale (NRS) in the Subset of Participants with ≥4-point Itch NRS at BaselineWeek 16

Trial Locations

Locations (65)

Johnson Dermatology

🇺🇸

Fort Smith, Arkansas, United States

Dermatology Research Associates

🇺🇸

Los Angeles, California, United States

Encore Medical Research

🇺🇸

Hollywood, Florida, United States

Conquest Research

🇺🇸

Winter Park, Florida, United States

Allergy and Asthma Specialist

🇺🇸

Owensboro, Kentucky, United States

Arkansas Research Trials

🇺🇸

North Little Rock, Arkansas, United States

Revival Research Institute, LLC

🇺🇸

Troy, Michigan, United States

ActivMed Practices & Research, Inc.

🇺🇸

Portsmouth, New Hampshire, United States

Metropolitan Dermatology - Clark

🇺🇸

Kenilworth, New Jersey, United States

Oregon Dermatology and Research Center

🇺🇸

Portland, Oregon, United States

DermDox Centers for Dermatology

🇺🇸

Camp Hill, Pennsylvania, United States

Progressive Clinical Research

🇺🇸

San Antonio, Texas, United States

Center for Clinical Studies

🇺🇸

Webster, Texas, United States

Rejuvenation Dermatology

🇨🇦

Edmonton, Alberta, Canada

Wiseman Dermatology Research Inc.

🇨🇦

Winnipeg, Manitoba, Canada

CCA Medical Research

🇨🇦

Ajax, Ontario, Canada

Hamilton Allergy

🇨🇦

Hamilton, Ontario, Canada

Lynderm Research Inc.

🇨🇦

Markham, Ontario, Canada

FACET Dermatology

🇨🇦

Toronto, Ontario, Canada

Alpha Recherche Clinique

🇨🇦

Quebec, Canada

Xiangya Hospital Central South University

🇨🇳

Changsha, Hunan, China

Affiliated Hospital of Jiangsu University

🇨🇳

Zhenjiang, Jiangsu, China

The First Affiliated Hospital of Xi'an Jiaotong University

🇨🇳

Xi'an, Shaanxi, China

Huashan Hospital, Fudan University

🇨🇳

Shanghai, Shanghai, China

Zhejiang Provincial People's Hospital

🇨🇳

Hangzhou, Zhejiang, China

Renmin Hospital of Wuhan University

🇨🇳

Wuhan, China

Allergo-Derm Bakos Kft

🇭🇺

Szolnok, Jász-Nagykun-Szolnok, Hungary

Somogy Megyei Kaposi Mór Oktató Kórház

🇭🇺

Kaposvár, Somogy, Hungary

Markusovszky Egyetemi Oktatokorhaz

🇭🇺

Szombathely, Vas, Hungary

Medmare Bt

🇭🇺

Veszprém, Veszprém City, Hungary

Debreceni Egyetem Klinikai Kozpont

🇭🇺

Debrecen, Hungary

Yasumoto Dermatology Clinic

🇯🇵

Chikushino-city, Fukuoka, Japan

Takagi Dermatological Clinic

🇯🇵

Obihiro-shi, Hokkaido, Japan

Nomura Dermatology Clinic

🇯🇵

Yokohama-city, Kanagawa, Japan

Dermatology and Ophthalmology Kume Clinic

🇯🇵

Sakai City, Osaka, Japan

Nihonbashi Sakura Clinic

🇯🇵

Chuo-ku, Tokyo, Japan

Tachikawa Dermatology Clinic

🇯🇵

Tachikawa, Tokyo, Japan

The Catholic University of Korea, Incheon St. Mary's Hospital

🇰🇷

Bupyeong-gu, Incheon-gwangyeoksi [Incheon], Korea, Republic of

Korea University Ansan Hospital

🇰🇷

Ansan-si, Kyǒnggi-do, Korea, Republic of

Pusan National University Hospital

🇰🇷

Busan, Pusan-Kwangyǒkshi, Korea, Republic of

Chung-Ang University Hospital

🇰🇷

Dongjak-gu, Seoul-teukbyeolsi [Seoul], Korea, Republic of

National Medical Center

🇰🇷

Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of

Hallym University Kangnam Sacred Heart Hospital

🇰🇷

Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of

Cryptex Investigación Clínica S.A. de C.V.

🇲🇽

Cuauhtémoc, Ciudad De México, Distrito Federal, Mexico

RM Pharma Specialists

🇲🇽

Mexico City, Distrito Federal, Mexico

Trials in Medicine

🇲🇽

Mexico City, Distrito Federal, Mexico

Centro de Atención en Enfermedades Inflamatorias CATEI

🇲🇽

Guadalajara, Jalisco, Mexico

Eukarya PharmaSite

🇲🇽

Monterrey, Nuevo León, Mexico

Scientia Investigacion Clinica S.C.

🇲🇽

Chihuahua, Mexico

Centro de Investigacion Clinica de Oaxaca

🇲🇽

Oaxaca, Mexico

MICS Centrum Medyczne Warszawa

🇵🇱

Warszawa, Mazowieckie, Poland

Diamond Clinic

🇵🇱

Krakow, Małopolskie, Poland

Specderm Poznanska

🇵🇱

Bialystok, Podlaskie, Poland

Centrum Badan Klinicznych PI-House sp. z o.o.

🇵🇱

Gdansk, Pomorskie, Poland

"DERMED" Centrum Medyczne Sp. z o.o.

🇵🇱

Lodz, Łódzkie, Poland

Dermoklinika - Centrum Medyczne spółka cywilna M. Kierstan, J. Narbutt, A. Lesiak

🇵🇱

Lodz, Łódzkie, Poland

Chang Gung Memorial Hospital at Kaohsiung

🇨🇳

Kaohsiung Niao Sung Dist, Kaohsiung, Taiwan

New Taipei Municipal TuCheng Hospital

🇨🇳

New Taipei City, New Taipei, Taiwan

Chung Shan Medical University Hospital

🇨🇳

Taichung City, Taichung, Taiwan

Tri-Service General Hospital

🇨🇳

Taipei City, Taipei, Taiwan

National Taiwan University Hospital - Hsinchu branch

🇨🇳

Hsinchu, Taiwan

Taipei Medical University Shuang Ho Hospital

🇨🇳

New Taipei, Taiwan

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

Taipei Veterans General Hospital

🇨🇳

Taipei, Taiwan

Chang Gung Medical Foundation-Linkou Branch

🇨🇳

Taoyuan, Taiwan

© Copyright 2025. All Rights Reserved by MedPath